HIGHLIGHTS
- who: Federica Papaccio and collaborators from the Gallicano Dermatological Institute, IRCCS, Rome, Italy have published the article: A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPAR Agonist, in the Journal: Cells 2022, 11, x FOR PEER REVIEW of 12/01/2016
- what: Starting from these two different pieces of evidence, to better elucidate a potential effect of PGZ in vitiligo cells, the authors focused the analysis on peculiar vitiligo fibroblast characteristics. Among the various pathogenetic hypotheses, the research has been particularly effective in the explanation of non-immunological factors, demonstrating the presence of metabolic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.